Terms: = Leukemia AND ELL, P55199, 8178, ENSG00000105656, ELL1, C19orf17
110 results:
1. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid leukemia Harboring
Jiang B; Zhao Y; Luo Y; Yu J; Chen Y; Ye B; Fu H; Lai X; Liu L; Ye Y; Zheng W; Sun J; He J; Zhao Y; Wei G; Cai Z; Huang H; Shi J
Cell Transplant; 2024; 33():9636897231225821. PubMed ID: 38270130
[No Abstract] [Full Text] [Related]
2. Droplet Digital PCR for Oncogenic KMT2A Fusion Detection.
Young AL; Davis HC; Challen GA
J Mol Diagn; 2023 Dec; 25(12):898-906. PubMed ID: 37813299
[TBL] [Abstract] [Full Text] [Related]
3. AFF4 globally affects the release of paused RNA polymerase II in HEL cells.
Yang ZM; Zhang G; Wei G; Jing LL; Yu M
Yi Chuan; 2023 Aug; 45(8):658-668. PubMed ID: 37609817
[TBL] [Abstract] [Full Text] [Related]
4. Stratification and therapeutic potential of ell in cytogenetic normal acute myeloid leukemia.
Zha J; Zhong M; Pan G; Chen Q; Jiang Y; Lai Q; Tan J; Zhou H; Wu H; Xu B
Gene; 2023 Mar; 856():147110. PubMed ID: 36543308
[TBL] [Abstract] [Full Text] [Related]
5. A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth.
Li X; Yao Y; Wu F; Song Y
J Hematol Oncol; 2022 Apr; 15(1):41. PubMed ID: 35395864
[TBL] [Abstract] [Full Text] [Related]
6. Sequence, structural and functional conservation among the human and fission yeast ell and EAF transcription elongation factors.
Sweta K; Dabas P; Sharma N
Mol Biol Rep; 2022 Feb; 49(2):1303-1320. PubMed ID: 34807377
[TBL] [Abstract] [Full Text] [Related]
7. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract] [Full Text] [Related]
8. Arabidopsis thaliana possesses two novel ell associated factor homologs.
Dabas P; Dhingra Y; Sweta K; Chakrabarty M; Singhal R; Tyagi P; Behera PM; Dixit A; Bhattacharjee S; Sharma N
IUBMB Life; 2021 Sep; 73(9):1115-1130. PubMed ID: 34089218
[TBL] [Abstract] [Full Text] [Related]
9. Structure, function and inhibition of critical protein-protein interactions involving mixed lineage leukemia 1 and its fusion oncoproteins.
Li X; Song Y
J Hematol Oncol; 2021 Apr; 14(1):56. PubMed ID: 33823889
[TBL] [Abstract] [Full Text] [Related]
10. Rare
Panagopoulos I; Andersen K; Eilert-Olsen M; Rognlien AG; Munthe-Kaas MC; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(2):121-131. PubMed ID: 33608309
[TBL] [Abstract] [Full Text] [Related]
11. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.
Matsuo H; Yoshida K; Nakatani K; Harata Y; Higashitani M; Ito Y; Kamikubo Y; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Miyano S; Meggendorfer M; Haferlach C; Ogawa S; Adachi S
Blood Adv; 2020 Oct; 4(19):4623-4631. PubMed ID: 32991719
[TBL] [Abstract] [Full Text] [Related]
12. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.
Juul-Dam KL; Ommen HB; Nyvold CG; Walter C; Vålerhaugen H; Kairisto V; Abrahamsson J; Alm SJ; Jahnukainen K; Lausen B; Reinhardt D; Zeller B; von Neuhoff N; Fogelstrand L; Hasle H
Br J Haematol; 2020 Jul; 190(2):198-208. PubMed ID: 32175599
[TBL] [Abstract] [Full Text] [Related]
13. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid leukemia.
Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
[TBL] [Abstract] [Full Text] [Related]
14. Rare myeloid sarcoma with KMT2A (MLL)-ell fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
15. CDK9: a signaling hub for transcriptional control.
Bacon CW; D'Orso I
Transcription; 2019 Apr; 10(2):57-75. PubMed ID: 30227759
[TBL] [Abstract] [Full Text] [Related]
16. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
[TBL] [Abstract] [Full Text] [Related]
17. [Characteristics and prognosis in adult acute myeloid leukemia patients with MLL gene rearrangements].
Gong XY; Wang Y; Liu BC; Wei H; Li CW; Li QH; Zhao JW; Zhou CL; Lin D; Liu KQ; Wei SN; Gong BF; Zhang GJ; Liu YT; Zhao XL; Li Y; Gu RX; Qiu SW; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2018 Jan; 39(1):9-14. PubMed ID: 29551026
[No Abstract] [Full Text] [Related]
18. The E3 ubiquitin ligase Triad1 influences development of Mll-ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract] [Full Text] [Related]
19. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract] [Full Text] [Related]
20. Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.
Matsuo H; Iijima-Yamashita Y; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):41-46. PubMed ID: 29067751
[TBL] [Abstract] [Full Text] [Related]
[Next]
